Lifecell International Profile
Key Indicators
- Authorised Capital ₹ 37.06 Cr
- Paid Up Capital ₹ 16.70 Cr
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 442.38 Cr
- Revenue Growth -36.35%
- Profit Growth 852.00%
- Ebitda 174.05%
- Net Worth 87.58%
- Total Assets -39.04%
About Lifecell International
Lifecell International Private Limited (LIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 June 2004 and has a history of 20 years and seven months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Asia Cryo-Cell Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 37.06 Cr and a paid-up capital of Rs 16.70 Cr.
The company has closed loans amounting to ₹442.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lifecell International Private Limited India are Sumanth Sarangapani as CEO and Sudha Venkataraman as Company Secretary. Deepak Abhayakumar, Abhaya Mayur, Sunny Sharma, and One other member serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85196TN2004PTC053577
- Company No.
053577
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Lifecell International Private Limited offer?
Lifecell International Private Limited offers a wide range of products and services, including Health Care Service, Medical Test Services, Medical Treatment Services, Pregnancy Care Treatment, Diagnostic Imaging & Pathology Labs, Medical Surgery & Treatment Centres, Medical Facilities, Medical Laboratory Instruments, Corona Test Kit, HR & Manpower Recruitment Solutions.
Who are the key members and board of directors at Lifecell International?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhaya Mayur  | Managing Director | 27-May-2008 | Current |
| Sumanth Sarangapani | CEO | 01-Sep-2023 | Current |
| Sudha Venkataraman | Company Secretary | 01-Jul-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Abhayakumar | Director | 30-Jun-2024 | Current |
| Sunny Sharma | Director | 22-Sep-2021 | Current |
| Sumona Chakraborty | Director | 01-Jul-2022 | Current |
Financial Performance of Lifecell International.
Lifecell International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.35% decrease. The company also saw a substantial improvement in profitability, with a 852% increase in profit. The company's net worth Soared by an impressive increase of 87.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifecell International?
In 2023, Lifecell International had a promoter holding of 84.33% and a public holding of 15.67%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innvolution Healthcare Private LimitedSunny Sharma is a mutual person
Innovation Imaging Technologies Private LimitedSunny Sharma is a mutual person
H S Pathology Private LimitedDeepak Abhayakumar and Abhaya Mayur are mutual person
Marksans Pharma LimitedSunny Sharma is a mutual person
Venkata Narayana Active Ingredients Private LimitedDeepak Abhayakumar is a mutual person
Orbimed Advisors India Private LimitedSunny Sharma is a mutual person
Charges (Loans)
₹0
₹442.38 Cr
Charges Breakdown by Lending Institutions
- Others : 429.38 Cr
- Indian Bank : 7.00 Cr
- Axis Bank Limited : 6.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2019 | Others | ₹31.00 Cr | Satisfied |
| 18 Feb 2019 | Others | ₹31.00 Cr | Satisfied |
| 07 Sep 2018 | Others | ₹70.00 Cr | Satisfied |
| 15 Dec 2017 | Axis Bank Limited | ₹6.00 Cr | Satisfied |
| 14 Nov 2017 | Others | ₹70.00 Cr | Satisfied |
How Many Employees Work at Lifecell International?
Lifecell International has a workforce of 1249 employees as of Dec 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifecell International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifecell International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
